Short Interest in Adaptimmune Therapeutics plc (NASDAQ:ADAP) Expands By 31.0%
MarketBeat
Adaptimmune Therapeutics plc (NASDAQ:ADAP - Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 5,830,000 shares, an increase of 31.0% from the April 30th total of 4,450,000 shares. Based on an average trading volume of 1,940,000 shares, the days-to-cover ratio is presently 3.0 days. Currently, 2.6% of the company's stock are sold short.
NASDAQ:ADAP